Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.470
+0.060 (4.26%)
At close: May 1, 2026, 4:00 PM EDT
1.470
0.00 (0.00%)
Pre-market: May 4, 2026, 6:18 AM EDT
Autolus Therapeutics Employees
As of December 31, 2025, Autolus Therapeutics had 754 total employees, including 752 full-time and 2 part-time employees. The number of employees increased by 104 or 16.00% compared to the previous year.
Employees
754
Change (1Y)
104
Growth (1Y)
16.00%
Revenue / Employee
$99,984
Profits / Employee
-$381,337
Market Cap
391.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 754 | 104 | 16.00% | 752 | 2 |
| Dec 31, 2024 | 650 | 179 | 38.00% | 647 | 3 |
| Dec 31, 2023 | 471 | 67 | 16.58% | 463 | 8 |
| Dec 31, 2022 | 404 | 77 | 23.55% | 399 | 5 |
| Dec 31, 2021 | 327 | -57 | -14.84% | 324 | 3 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 117 |
| Century Therapeutics | 78 |
| Lineage Cell Therapeutics | 77 |
| Larimar Therapeutics | 71 |
| X4 Pharmaceuticals | 45 |
AUTL News
- 4 days ago - Autolus Therapeutics Announces Initiative to Support Operational Efficiency and Cost Reduction - GlobeNewsWire
- 12 days ago - Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Autolus Therapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 25 days ago - Autolus Therapeutics Transcript: Status update - Transcripts
- 26 days ago - Autolus Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Autolus Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates - GlobeNewsWire
- 6 weeks ago - Autolus Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 27, 2026 - GlobeNewsWire